Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
12/2007
12/20/2007US20070292455 chimeric dna viruses; disrupted open reading frame; for treating or preventing viral infections; immunogens
12/20/2007US20070292395 Use of viruses and virus-resistant microorganisms for controlling microorganism populations
12/19/2007EP1866422A2 Method of increasing the function of an aav vector
12/19/2007EP1597376B1 Chicken rna polymerase i promoter and the use thereof
12/19/2007EP1090033B2 Particles of hcv envelope proteins: use for vaccination
12/19/2007EP0772689B1 Retroviral vectors having a reduced recombination rate
12/19/2007CN101090981A Porcine reproductive and respiratory syndrome isolates and methods of use
12/19/2007CN101090966A Attenuated chimeric flavivirus bearing attenuated japanese encephalitis virus gene as backbone
12/19/2007CN101089177A Type II genetic marker strain of porcine circovirus and its application
12/18/2007US7309598 gM-negative EHV-mutants
12/18/2007US7309495 For immunizing a cat against a hemorrhagic feline calicivirus (hFCV)
12/13/2007WO2007143442A2 A novel virulence determinant within the e2 structural glycoprotein of classical swine fever virus
12/13/2007WO2007142241A1 Immunocompetent cell having anti-cd38 antibody on its cell surface
12/13/2007WO2007140522A1 Detection and use of antiviral resistance mutations
12/13/2007WO2007120193A3 Bionanomaterials and their synthesis
12/13/2007US20070287174 Peptide mediated synthesis of metallic and magnetic materials
12/13/2007US20070287146 Method for expressing a functional membrane-bound receptor protein using budded baculovirus
12/13/2007US20070286842 serine protease inhibitors, for the treatment of hepatitis c virus infections
12/13/2007CA2655175A1 Detection and use of antiviral resistance mutations
12/12/2007EP1865066A2 Genetic immunisation against cervical carcinoma
12/12/2007EP1865065A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
12/12/2007EP1863906A1 Use of a combination of myxoma virus and rapamycin for therapeutic treatment
12/12/2007EP1863527A2 Mannose immunogens for hiv-1
12/12/2007EP1137792B9 A recombinant vector expressing multiple costimulatory molecules and uses thereof
12/12/2007EP1078051B1 Phage-display system for the selection of correctly folded proteins
12/12/2007EP0841942B2 Method for industrially producing a japanese encephalitis vaccine, and resulting vaccine
12/12/2007CN101085346A Attenuated pestiviruses
12/12/2007CN100354431C Method of PCR testing of pooled blood samples
12/12/2007CN100354426C Viral core protein-cationic lipid-nucleic acid-delivery complexes
12/12/2007CN100354425C Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
12/12/2007CN100354414C Pseudo-rabies gE/gI-gene loss poison strain, killed vaccine containing it and use
12/11/2007US7307066 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
12/11/2007US7306794 Methods and compositions for the treatment of defects in lipoprotein metabolism
12/11/2007US7306793 Defective recombinant adenoviruses expressing cytokines for antitumor treatment
12/06/2007WO2007122278A3 Novel spodoptera exigua nucleopolyhedrovirus genotypes and use thereof in controlling blights produced by this insect
12/06/2007WO2007053188A3 Production of multivalent virus like particles
12/06/2007US20070281911 Use of Adefovir or Tenofovir for Inhibiting Mmtv-Like Viruses Involved in Breast Cancer and Primary Biliary Cirrhosis
12/06/2007US20070280963 Method for Producing Non-Pathogenic Helper Virus-Free Preparations of Herpes Virus Amplicon Vectors, the Helper Virus and the Cells Used in this Method, the Corresponding Generic Tools, as Well as the Applications of These Non-Pathogenic Amplicon Vectors
12/06/2007US20070280962 HBV core antigen particles with multiple immunogenic components attached via peptid ligands
12/06/2007US20070280961 cDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses and process for the production of such viruses
12/06/2007US20070280955 Novel virulence determinant within the E2 structural glycoprotein of classical swine fever virus
12/06/2007US20070280908 Treatment of diabetes with synthetic beta cells
12/05/2007EP1862550A1 Assembly of wild-type and chimeric influenza virus-like particles (VLPs)
12/05/2007EP1223976B1 Novel process for making human papillomavirus virus-like particles with improved properties
12/05/2007CN101084011A Porcine reproductive and respiratory syndrome virus strains and compositions
12/05/2007CN101082042A Application of artificial reconstructed defect type human 3-type adenovirus
12/05/2007CN101082041A Novel vaccinia virus strain, vaccinia live attenuated vaccine and preparation method thereof
12/04/2007US7303910 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
12/04/2007US7303901 Catalyzes ligation of single-stranded DNA with a high degree of efficiency
12/04/2007CA2121241C Porcine reproductive respiratory syndrome vaccine and diagnostic
11/2007
11/29/2007WO2007136882A2 Radiating element for radar array antenna
11/29/2007WO2007136585A2 Immunotherapeutic compositions and methods
11/29/2007WO2007002793A3 Chimeric sindbis-eastern equine encephalitis virus and uses thereof
11/29/2007WO2004037202A3 Gb virus c and methods of treating viral infections
11/29/2007US20070275449 Method for Large-Scale Production, Isolation, Purification and the Uses of Multi-Type Recombinant Adeno-Associated Virus Vectors
11/29/2007US20070275015 Sequences encoding the pre-membrane and envelope proteins of West Nile virus having an attenuating mutation and the capsid and non-structural proteins of Yellow Fever virus; chimeric flavivirus
11/29/2007US20070275013 Vaccine and Method of Use
11/29/2007US20070275010 Mva Vaccines
11/29/2007US20070275002 Use Of Proteins And Peptides Encoded By The Genome Of A Novel Sars-Associated Coronavirus Strain
11/29/2007US20070274988 Kiaa0779, Splice Variants Thereof, and Methods of Their Use
11/29/2007US20070274908 Methods and compositions related to adenoassociated virus-phage particles
11/29/2007CA2652595A1 Defective interfering virus
11/28/2007EP1860188A2 Human cytokine receptor
11/28/2007EP1859813A1 Remedy for disease associated with apoptotic degeneration in ocular cell tissue with the use of siv-pedf vector
11/28/2007EP1858917A2 Varicella zoster virus vaccine
11/28/2007EP1858915A1 Variants of hepatitis b virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof
11/28/2007EP1858332A2 Lentiviral vectors and their use
11/28/2007EP1412486B1 Method for virus propagation
11/28/2007CN101080488A Novel method for the production and purification of adenoviral vectors
11/28/2007CN101080239A Stabilized HBc chimer particles as therapeutic vaccine for chronic hepatitis
11/28/2007CN100351385C Herpes viruses for immune modulation
11/28/2007CN100351279C Preparation of monodispersion high molecular nanometer sphere using envelop virus as template
11/27/2007US7300785 Culturing circular ssDNA viruses for the production of vaccines
11/27/2007US7300650 Reovirus for the treatment of neoplasia
11/27/2007CA2167274C Inactivated respiratory syncytial viral vaccines
11/22/2007WO2007132763A1 Method for proliferation of influenza virus
11/22/2007WO2007131352A1 High-affinity antagonists of elr-cxc chemokines
11/22/2007WO2006091511A8 Primate t-lymphotropic viruses
11/22/2007WO2005067478A3 Recombinant icosahedral virus like particle production in pseudomonads
11/22/2007WO2004101765A3 Methods and apparatus for adeno associated virus purification
11/22/2007WO2003006672A3 Antimicrobial nucleic acid antibodies, and materials and methods for making and using same
11/22/2007US20070270351 Methods and Reagents for Regulation of Cellular Responses in Biological Systems
11/22/2007US20070269888 Bioreactor Assembly Comprising at Least One Tray-Like Rocking Platform
11/22/2007US20070269880 Stabilizing Solutions for Submicronic Particles, Methods for Making the Same and Methods of Stabilizing Submicronic Particles
11/22/2007US20070269856 Viral Purification Methods
11/22/2007US20070269461 Recombinant Vaccine Against Japanese Encephalitis Virus (Jev) Infection and a Method Thereof
11/22/2007US20070269457 Immunotherapeutic compositions and methods
11/22/2007US20070269445 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a PRRSV and a method of detecting a PRRSV
11/22/2007CA2652094A1 High-affinity antagonists of elr-cxc chemokines
11/22/2007CA2651285A1 Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments
11/21/2007EP1856250A2 New live virus vaccines
11/21/2007EP1856141A1 N protein mutants of porcine reproductive and respiratory syndrome virus
11/21/2007EP1356071B1 Genetically engineered herpes virus for the treatment of cardiovascular disease
11/21/2007EP1187919B1 Recombinant adenoviruses encoding the sodium/iodide symporter (nis)
11/21/2007EP1170363B1 Virus envelope vector for gene transfer
11/21/2007EP1036182B1 Method and means for producing high titer, safe, recombinant lentivirus vectors
11/21/2007CN101076591A Novel human virus causing respiratory tract infection and uses thereof
11/20/2007US7297762 Avian pancreatic polypeptide/scaffold; phage display libraries
11/20/2007US7297680 Mixture comprising sialinated erythropoietin (EPO) for use in generating stable, human, recombinant proteins that are modified post-translationally
11/20/2007US7297542 Virology and gene therapy; modified fiber knob retains its ability to trimerize and retains its native biosynthesis profile